Search Results

Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, and Palantir Technologies Inc.

Parexel today announced that Jamie Macdonald will retire and transition his role as Chief Executive Officer (CEO) to the company’s Chief Operating and Growth Officer Peyton Howell effective May 15, 2024.

Parexel today announced today announced it has been named “Best Contract Research Organization” in the Full-Service Provider category at the 19th Annual Scrip Awards.

Parexel, one of the world’s largest clinical research organizations providing the full range of Phase I to IV clinical development services, announced that Chief Medical Officer and Global Head, Oncology Center of Excellence, Amy McKee, M.D., has been named to the PharmaVoice 100 list of influential people in the life sciences industry.

Parexel today announced the appointments of Michael Bruun, Partner, Global co-Head of Private Equity, Goldman Sachs Asset Management, and John Groetelaars, Non-Executive Director and former Interim CEO of Dentsply Sirona and former President & CEO at Hillrom, to its Board of Directors.

Parexel and Partex announced a preferred strategic alliance designed to leverage artificial intelligence -powered solutions to accelerate drug discovery and development for biopharmaceutical customers worldwide and de-risk the assets in their portfolios.

Parexel today announced the appointment of Scott Smith, M.D., Ph.D. as Senior Vice President, Global Therapeutic Area Head – Hematology.